Grace Therapeutics
Manufacturing · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2 Tower Center Blvd Ste 1101G, East Brun...Phone Number
(646) 809-6839Website
www.gtrx.comRevenue
-Industry
About Grace Therapeutics
Grace Therapeutics is a pharmaceutical company with a focus on rare and orphan diseases. Grace's strategy is to develop novel delivery technologies that dramatically improve the clinical outcomes of drugs previously approved for use in humans. Its selective pipeline screening model supports the development of differentiated products with a unique evidence-based and outcomes-driven value proposition . ITs pipeline consists of three distinct assets all in late stage clinical development for the treatment of Postherpetic Neuralgia, Subarachnoid Hemorrhage, and Ataxia Telangiectasia. The company intend to pursue multiple commercialization options for these products including their proprietary platform technologies for maximum value creation.Explore more
Grace Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Grace Therapeutics
Compare insights from companies similar to Grace Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Grace Therapeutics
1-10
Private
$30.1M
2014
LH
Laurent HarveyVice President Clinical and NonClinical Affairs
Grace Therapeutics Tech Stack
A closer look at the technologies used by Grace Therapeutics
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Grace Therapeutics
Sign Up For FreeTo access detailed company insights
Grace Therapeutics is a pharmaceutical company with a focus on rare and orphan diseases. Grace's strategy is to develop novel delivery technologies that dramatically improve the clinical outcomes of drugs previously approved for use in humans. Its selective pipeline screening model supports the development of differentiated products with a unique e... Read More
